A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle.

AP Photo/Ted S. Warren

The first US-based clinical trial of a coronavirus vaccine is expanding to soon begin recruiting healthy volunteers in Georgia.

The trial is testing a vaccine candidate produced by the upstart biotech Moderna. The first participant was dosed on March 16 at the first study location, Kaiser Permanente Washington’s research clinic in Seattle.

The second location at Emory University is not open for business yet, but aims to start recruiting participants within the next week, a university spokesperson told Business Insider. 

The National Institutes

Read More At Article Source | Article Attribution